Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties
October 28 2020 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced that it has begun field testing to
evaluate the emergence and agronomics of winter Camelina sativa
varieties. The testing of these winter varieties in the 2020/2021
winter season is part of Yield10’s continued development of
Camelina sativa in the medium term for use at commercial scale as a
cash cover crop for North America.
Having previously evaluated the Camelina sativa winter varieties
in 2019/2020, Yield10 continues to pursue commercial efforts to
leverage its technology in the potential high growth cash cover
crop market. Cover crops are becoming increasingly important to
improve the sustainability of food production by improving soil
health, reducing unwanted leaching of nutrients into the water
supply, and enhancing economic returns for the farmer.
The objectives of the study are to determine the seed and oil
yield potential of winter Camelina varieties, and to scale up
certain plant lines to support conducting larger studies. The field
tests will evaluate the best performing wild-type and doubled
haploid lines from the 2019/2020 winter season. Doubled haploid
Camelina lines are expected to have more uniform and stable
performance, making them attractive as a foundation for Camelina
development and insertion of Yield10’s performance and product
traits.
“We were very pleased with the seedling emergence and overall
crop performance of our wild-type and doubled haploid winter
Camelina lines, which were tested under the extreme winter
conditions encountered in Canada in the late 2019/2020 season,”
said Kristi Snell, Ph.D., Chief Science Officer of Yield10
Bioscience. “We are testing our best performing winter lines this
year at sites in the U.S. and in Canada to generate additional crop
performance data in different geographic locations. This field test
will enable us to evaluate the performance of the lines, as well as
provide the opportunity to generate more seed to enable larger
scale plantings in the future -- two key steps for demonstrating
the seed and oil yield potential of the crop. We are building value
in our germplasm foundation which will enable us to combine our
proprietary traits in both winter and spring Camelina varieties,
expanding acreage potential for the crop.”
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
developing crop innovations for sustainable global food security.
The Company uses its “Trait Factory” including the “GRAIN” big data
mining trait gene discovery tool as well as the Camelina oilseed
“Fast Field Testing” system to develop high value seed traits for
the agriculture and food industries. As a path toward
commercialization of novel traits, Yield10 is pursuing a partnering
approach with major agricultural companies to drive new traits into
development for canola, soybean, corn, and other commercial crops.
The Company is also developing improved Camelina varieties as a
platform crop for the production and commercialization of
nutritional oils, proteins, and PHA biomaterials. The Company’s
expertise in oilseed crops also extends into canola, where it is
currently field-testing novel yield traits to generate data to
drive additional licensing opportunities. Yield10 is headquartered
in Woburn, MA and has an Oilseeds Center of Excellence in
Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for
Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, statements regarding the Company’s intentions with
regard to development of Camelina sativa for use at commercial
scale as a cover crop for North America, the use of cover crops as
a way to open up large areas for new crops producing novel products
by complementing and not competing for acres with major food and
feed crops while increasing farm revenue, the potential size of the
cash cover crop market, whether doubled haploid Camelina lines will
have more uniform and stable performance, plans to complete field
tests with winter Camelina in 2021, the results and outcome of, and
information gathered from, those tests, the ability to generate
value from Camelina oil and meal, including but not limited to the
ability to use the results of the tests in future studies or
licensing, collaboration or other commercial activities, and
whether the Company’s traits will increase seed yield or boost oil
content, constitute forward-looking statements.
Such forward-looking statements are subject to a number of risks
and uncertainties that could cause actual results to differ
materially from those anticipated, including the risks and
uncertainties detailed in Yield10 Bioscience's filings with the
Securities and Exchange Commission. Yield10 assumes no obligation
to update any forward-looking information contained in this press
release or with respect to the matters described herein.
Contacts: Yield10 Bioscience:Lynne H. Brum,
(617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024